As of May 2022 Zoetis has a market cap of $76.50 Billion. This makes Zoetis the world's 181th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $76.50 B | -33.74% |
2021 | $115.45 B | 46.79% |
2020 | $78.65 B | 24.98% |
2019 | $62.93 B | 53.42% |
2018 | $41.02 B | 16.86% |
2017 | $35.10 B | 32.8% |
2016 | $26.43 B | 10.91% |
2015 | $23.83 B | 10.49% |
2014 | $21.57 B | 31.98% |
2013 | $16.34 B |
On May 21st, 2022 the market cap of Zoetis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $294.40 B | 284.81% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $283.95 B | 271.16% | ๐บ๐ธ USA |
![]() Sanofi SNY | $135.85 B | 77.57% | ๐ซ๐ท France |
![]() Merck MRK | $236.57 B | 209.22% | ๐บ๐ธ USA |
![]() Phibro Animal Health
PAHC | $0.75 B | -99.02% | ๐บ๐ธ USA |
![]() Kindred Biosciences
KIN | $0.42 B | -99.45% | ๐บ๐ธ USA |
![]() Heska Corporation
HSKA | $1.08 B | -98.58% | ๐บ๐ธ USA |